European Commission explains its hTEPs (human tissue engineered products) decision and the new single framework
This article was originally published in Clinica
Executive Summary
Advanced therapy products, while considered a subset of pharmaceuticals, will not be subject to the same technical requirements as conventional medicines. That is the statement made by the European Commission in its consultation paper on the proposal for a Community regulatory framework on advanced therapies.